IPO Plus - IPO

Name▼ / Code▼	Industry	Offer Price	Lot Size	Entry Fee	Closing Date	Grey Market Date▼	Listing Date▲
IMPACT Therap-B 07630.HK	Biotechnology - Pharmaceuticals	19.75-21.75	200	4,393.88	2026/05/08	2026/05/12	2026/05/13
Metis TechBio-P 07666.HK	Next-generation information technology	10.5	500	5,302.95	2026/05/08	2026/05/12	2026/05/13
Robotphoenix 06871.HK	Advanced hardware and software	30.5	100	3,080.75	2026/05/13	2026/05/15	2026/05/18

Name▼

Code▼

Industry

Offer Price

Lot Size

Entry Fee

Closing Date

Grey Market Date▼

Listing Date▲

IMPACT Therap-B
07630.HK

Biotechnology - Pharmaceuticals

19.75-21.75

200

4,393.88

2026/05/08

2026/05/12

2026/05/13

Metis TechBio-P
07666.HK

Next-generation information technology

10.5

500

5,302.95

2026/05/08

2026/05/12

2026/05/13

Robotphoenix
06871.HK

Advanced hardware and software

30.5

100

3,080.75

2026/05/13

2026/05/15

2026/05/18

Summary

We are an industrial robotics company in China, specializing in the design, development, manufacturing and commercialization of industrial robots and the offering of integrated robotics solutions, dedicated to the application scenarios in the light industry. Leveraging our proprietary robot bodies, control and vision systems, and manufacturing process, we have established an all-inclusive technology ecosystem to achieve at scale intelligent decision-making, environmental perception, precise manipulation, and autonomous mobility. We are the fourth largest domestic company, in terms of revenue in 2025, offering industrial robots and related robotics solutions in China dedicated to the application scenarios in the light industry, according to the F&S Report. We are also among a select few robotics companies in China with a coverage of industrial robots and related robotics solutions at scale, according to the same source, empowering enterprise customers in various industry sectors to enhance productivity level, optimize production costs, and improve product quality, ultimately driving their intelligent transformation. We curate a portfolio of industrial robots purpose-built for the application scenarios in the light industry in particular in China, spanning parallel robots (Bat series), AGV/AMR mobile robots (Camel series), SCARA robots (Python series), wafer handling robots (Lobster series), and six-axis industrial robots (Mantis series), powered by our proprietary core technologies in control and vision systems (Gorilla and Kingkong series). Building upon our robotic portfolio, we also offer integrated robotics solutions based in intelligent automation systems to address the specific application scenarios in smart manufacturing. We launch these solutions with various degrees of customization to support a wide range of automation functions, including among others, loading and unloading, sorting, picking and placing, packing, vision detection, assembly and gluing systems. Throughout the Track Record Period, our business has been substantially driven by large-scale, integrated robotics solutions we offered, which have consistently accounted for the majority of our revenue. Our key projects during the Track Record Period are primarily robotics solutions sold directly to direct sales customers, with a strong focus on automation for warehouse logistics and loading and unloading applications, alongside packaging and assembly. The value of these projects is significant, and as of December 31, 2025, we maintained a robust pipeline of future revenue from projects scheduled for completion in 2026. The specific robots utilized within our robotics solutions involve Bat Series, Camel series, Python series, Mantis series and vision systems. All of our industrial robots and related robotics solutions are designated Specialist Technology Products as defined under Chapter 18C of the Listing Rules. Our Directors are of the view that our industrial robots and related robotics solutions fall within an acceptable sector of a Specialist Technology Industry as defined under Chapter 18C of the Listing Rules on the following basis, as advised by Frost & Sullivan: (1) our industrial robots of various series and Gorilla and Kingkong series controllers, designed for application scenarios in various industry sectors, are programmable products, and thus fall within the definition of robot technology, and (2) our integrated robotics solutions involve the application and integration of robots, computer software and vision detection system for the improved performance of tasks and automation processes. We boast a robotic architecture that centers around four foundational pillars unique to the essential functionalities of a skillful human worker, from “Brain,” “Eyes,” “Hands” to “Feet,” commanding intelligent decision-making, environmental perception, precise manipulation, and autonomous mobility. The “Brain” is embodied in our all-in-one control system, which enables intelligent decision-making to achieve high-speed, high-precision motion and real-time, multi-robot coordination. The “Eyes” represent our advanced vision system, which combines 3D imaging and deep-learning algorithms, mission-critical for high-accuracy dynamic tracking. The “Hands” combine advanced modeling technology with precision manufacturing to deliver consistent performance and industrial-grade reliability. The “Feet” consist of our mobile platform of proprietary hardware and scheduling software to support autonomous navigation and dynamic obstacle avoidance. Together, these capabilities form a cohesive, scalable technology substrate for our offerings. Source: Robotphoenix (06871) Prospectus (IPO Date : 2026/05/08)
Listing Market	MAIN
Industry	Advanced hardware and software
Background	H Shares
Major Business Area	China

Corporate Information

Substantial Shareholders	Zhang Sai (Total share: 22.55%); (H share: 22.55%) Yuhuan City State-owned Assets Investment Operation Group Co., Ltd. (Total share: 8.71%); (H share: 8.71%) Zhang Zichao (Total share: 7.88%); (H share: 7.88%) Broadband (Tianjin) Investment Management Co., Ltd. (Total share: 7.81%); (H share: 7.81%) Li Feng (Total share: 5.79%); (H share: 5.79%) Yuhuan City Equity Investment Fund Co., Ltd. (Total share: 5.72%); (H share: 5.72%)
Directors	Zhang Sai (Chairman and President and Executive Director) Zhang Zichao (Executive Vice President and Executive Director) Dou Zhiyuan (General Manager and Executive Director) Sun Tongliang (Executive Director) Lee Shen Kai (Non-Executive Director) Song Pengfei (Non-Executive Director) Wang Maike (Non-Executive Director) Wu Qingyao (Independent Non-Executive Director) Xiong Minghua (Independent Non-Executive Director) Zhao Fengmei (Independent Non-Executive Director) Zhou Shuang (Independent Non-Executive Director)
Company Secretary	Shum Kit Han Yang Xu
Principal Bankers	China Merchants Bank
Solicitors	Baker & McKenzie Grandway Law Offices King & Wood
Auditors	Ernst & Young
Registered Office	Room 1912, 19/F., Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong
Share Registrars	Tricor Investor Services Ltd. [Tel: (852) 2980-1333]
Share Registrars Tel No	(852) 2980-1333
Internet Address	http:// www.robotphoenix.com
Email Address
Tel No	(86 400) 116-0626
Fax No

Real-time Futures	IPO Plus	Company Announcement
Top 20	Highs/ Lows	Company Dividend
Local Indices	DTDC RMB Traded Stocks	Result Announ. Schedule
World Indices	BioTech Stocks	Research Report
China Indices	Second Listing Stocks	Result Announ. News
Index Constituents	Short Selling	Corp. Event Search
H Shares (All)	ADR	Economic Calendar
Red Chips (All)	A+H+ADR	Economic Database
GEM (All)	A+H	Economic Data Chart
Industries	Shareholding Disclosures	World Interest Rates